Alpha Tau to Participate in May Investor Conferences

Provided By GlobeNewswire

Last update: May 6, 2025

JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will presentation in the following investor conferences in May 2025.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (11/21/2025, 4:00:00 PM)

0.3191

+0.03 (+10.03%)

DRTSW Overview

DRTSW Technical Analysis Report

DRTSW Fundamental Analysis Report

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (11/21/2025, 4:10:09 PM)

After market: 3.75 -0.07 (-1.83%)

3.82